A Study of Tranexamic Acid (XP12B) in Women With Heavy Menstrual Bleeding

Status Completed

Clinical Trial Summary

This was a multicenter, open-label extension study for subjects completing either of 2 pivotal efficacy studies (NCT00401193 or NCT00386308). The study consisted of a treatment phase of 9 menstrual periods to assess the safety of tranexamic acid at an oral dose of 1.3 g administered 3 times per day for up to 5 days (maximum of 15 doses) during menstruation. After the last treatment period, a follow-up phone call occurred approximately 30 days (range 25 to 35 days) after the last dose of study drug.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Menorrhagia

Clinical Trial Details

NCT number	NCT01280981
Study type	Interventional
Source	Ferring Pharmaceuticals
Contact
Status	Completed
Phase	Phase 3
Start date	April 2007
Completion date	May 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02824224` - Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)	Phase 4
Withdrawn	`NCT01651468` - The Effect of the Nutraceutical "Hemofix" on the Coagulation System	N/A
Recruiting	`NCT02616731` - Oral Tranexamic Acid Versus Diosmin for Treatment of Menorrhagia in Women Using Copper IUD	Phase 1/Phase 2
Terminated	`NCT02087228` - Evaluation of the Endometrial Cavity After Endometrial Ablation	N/A
Withdrawn	`NCT00953641` - Vaginal Misoprostol for Cervical Ripening Prior to Endometrial Biopsy	Phase 3
Completed	`NCT01436903` - Chances for Success of CavatermTM Surgery as a Function of Uterus Probe Length	Phase 4
Withdrawn	`NCT00768742` - Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study	N/A
Completed	`NCT00156195` - Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids	Phase 3
Completed	`NCT00152256` - A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids	Phase 3
Completed	`NCT00160381` - A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids	Phase 3
Completed	`NCT02228174` - Sonography Guided Transcervical Ablation of Uterine Fibroids	N/A
Terminated	`NCT01969396` - Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology	N/A
Completed	`NCT00393198` - Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia	Phase 4
Completed	`NCT00386308` - Efficacy and Safety Study of XP12B in Women With Menorrhagia	Phase 3
Completed	`NCT00966264` - Hysterectomy and Levonorgestrel Releasing Intrauterine System (LNG-IUS) in the Treatment of Menorrhagia	Phase 3
Completed	`NCT00904709` - The Assessment of Tranexamic Acid in Women With Menorrhagia Who Have Bleeding Disorders	Phase 4
Recruiting	`NCT03670680` - Efficiency of Lina LibrataTM System	N/A
Completed	`NCT02584088` - Ultrasound Appearance of the Endometrium Post Radio-Frequency Ablation
Completed	`NCT02835391` - PerClot Compared to Usual Care in Gynaecology Procedures	N/A
Completed	`NCT02304510` - Prevalence of Heavy Menstrual Bleeding in Female Population Living in Beijing